Clinical trial · no report yet · Phase 3
AMADEUS
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
- NCT04173533 ↗
- Completed
- University of Birmingham
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| YouTube | 8 | |
| Podcasts | 6 | |
| X threads | 2 | |
| Bluesky threads | 2 |
The trial
ClinicalTrials.gov- Official title
- A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Acute Myeloid Leukemia; Myelodysplasia
- Interventions
- Oral azacitidine; Matched placebo
- Arms
- Control Group · Placebo comparator
- Experimental Group · Experimental
- Enrollment
- 326
- Primary outcomes
- Relapse free survival (RFS)
- Sponsor
- University of Birmingham
- Start
- Jun 14, 2019
- Primary completion
- Apr 29, 2026
- Results posted
- No
- Registry record
- NCT04173533 · updated Aug 14, 2026